Danaher (DHR)
(Delayed Data from NYSE)
$197.09 USD
-0.07 (-0.04%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $196.50 -0.59 (-0.30%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth A Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, Danaher Corporation has a PEG ratio of 2.83 compared to the Medical Services industry's PEG ratio of 1.52.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
DHR 197.09 -0.07(-0.04%)
Will DHR be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for DHR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DHR
Markel's Q2 Earnings Surpass Estimates, Premiums Rise Y/Y
International Markets and Danaher (DHR): A Deep Dive for Investors
DHR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
CVS or DHR: Which Is the Better Value Stock Right Now?
Here's Why Danaher (DHR) is a Strong Growth Stock
Other News for DHR
Danaher (DHR) Names Jonathan Leiken as New General Counsel
Danaher names Jonathan Leiken as General Counsel
Danaher Appoints Jonathan Leiken as General Counsel | DHR Stock News
Revvity Q2: Headwinds From China And Customers, Buy On Weakness
MCN: The Yield Is Nice, But This Fund Is Hard To Recommend